Jungfleisch J, Böttcher R, Talló-Parra M, Pérez-Vilaró G, Merits A, Novoa EM, Díez J. CHIKV infection reprograms codon optimality to favor viral RNA translation by altering the tRNA epitranscriptome. Nat Commun. Aug 11;13(1):4725. (2022)

Sisteré-Oró M, Wortmann DDJ, Andrade N, Aguikar A, Mayo de las Casas C, Gracia CasabalF, Torres S, Bona Salinas E,Raventos Soler L, Arcas A, Esparre C, Garcia B, Valarezo J, Rosell R, Güerri-Fernandez R, Gonzalez-Cao M, Meyerhans A. Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination. Front Immunol. Jul 5;13:908108. (2022)

Suñer C, Sibilio A, Martín J, Castellazzi CL, Reina O, Dotu I, Caballé A, Rivas E, Calderone V, Díez J, Nebreda AR, Méndez R. Macrophage inflammation resolution requires CPEB4-directed offsetting of mRNA degradation. Elife. Apr 20;11:e75873. (2022)

Lledó GM, Sellares J, Brotons C, Sans M, Diez J, Blanco J, Bassat Q, Sarukhan A, Miró JM, de Sanjosé S. Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition. Clin Microbiol Infect. Mar;28(3):315-318. doi: 10.1016/j.cmi.2021.11.015. (2022)

Sazonov I, Grebennikov D, Meyerhans A, Bocharov G. Sensitivity of SARS-CoV-2 Life Cycle to IFN Effects and ACE2 Binding Unveiled with a Stochastic Model. Viruses. Feb 15;14(2):403. (2022)

Bocharov G, Grebennikov D, Argilaguet J, Meyerhans A. Examining the cooperativity mode of antibody and CD8⁺ T cell immune responses for vaccinology. Trends Immunol. Oct;42(10):852-855. doi: 10.1016/j.it.2021.08.003. Epub 2021 Sep 21. PMID: 34561159. (2021)

Rox K, Heyner M, Krull J, Harmrolfs K, Rinne V, Hokkanen J, Perez Vilaro G, Díez J, Müller R, Kröger A, Sugiyama Y, Brönstrup M. Physiologically Based Pharmacokinetic/Pharmacodynamic Model for the Treatment of Dengue Infections Applied to the Broad Spectrum Antiviral Soraphen A. ACS Pharmacol Transl Sci. Aug 30;4(5):1499-1513. doi: 10.1021/acsptsci.1c00078. (2021)

Grebennikov D, Kholodareva E, Sazonov I, Karsonova A, Meyerhans A, Bocharov G. Intracellular Life Cycle Kinetics of SARS-CoV-2 Predicted Using Mathematical Modelling. Viruses. Aug 31;13(9):1735. doi: 10.3390/v13091735. PMID: 34578317; PMCID: PMC8473439. (2021).

Baquero-Perez B, Geers D, Díez J. From A to m 6 A: The Emerging Viral Epitranscriptome. Viruses. Jun 1;13(6):1049 (2021).

Bessonov, N., Bocharov, G., Meyerhans, A., Popov, V., and Volpert, V. Existence and Dynamics of Strains in a Nonlocal Reaction-Diffusion Model of Viral Evolution. SIAM Journal on Applied Mathematics 81(1): 107-128 (2021).

Sazonov, I., Grebennikov D, Meyerhans, A., and Bocharov, G. Markov Chain-Based Stochastic Modelling of HIV-1 Life Cycle in a CD4 T Cell. Mathematics 9(17): 2025 (2021).

Vogel-González M, Talló-Parra M, Herrera-Fernández V, Pérez-Vilaró G, Chillón M, Nogués X, Gómez-Zorrilla S, López-Montesinos I, Arnau-Barrés I, Sorli-Redó ML, Horcajada JP, García-Giralt N, Pascual J, Díez J, Vicente R, Güerri-Fernández R. Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection. Nutrients. Feb 9;13(2):562 (2021).

Lyonnais S, Sadiq SK, Lorca-Oró C, Dufau L, Nieto-Marquez S, Escriba T, Gabrielli N, Tan X, Ouizougun-Oubari M, Okoronkwo J, Reboud-Ravaux M, Gatell JM, Marquet R, Paillart JC, Meyerhans A, Tisné C, Gorelick RJ  & Mirambeau G. The HIV-1 nucleocapsid regulates its own condensation by phase-separated activity-enhancing sequestration of the viral protease during maturation. Viruses, 13, 2312. (2021)

Blevins WR, Ruiz-Orera J, Messeguer X, Blasco-Moreno B, Villanueva-Cañas JL, Espinar L, Díez J, Carey LB, Albà MM. Uncovering de novo gene birth in yeast using deep transcriptomics. Nat Commun. Jan 27;12(1):604. doi: 10.1038/s41467-021-20911-3. (2021)

Gomara MJ, Perez Y, Gomez-Gutierrez P, Herrera C, Ziprin P, Martinez JP, Meyerhans A, Perez JJ, Haro I. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide. Sci Rep. Sep 2;10(1):14430. doi: 10.1038/s41598-020-71404-0. (2020)

I Sazonov, D Grebennikov, M Kelbert, A Meyerhans, and G Bocharov. Viral Infection Dynamics Model Based on a Markov Process with Time Delay between Cell Infection and Progeny Production. Mathematics 8(8): 1207 (2020).

N Bessonov, G Bocharov, A Meyerhans, V Popov, V Volpert. Nonlocal reaction-diffusion model of viral evolution: Emergence of virus strains. Mathematics 8 (1), 117 (2020).

Bocharov G, Casella V, Argilaguet J, Grebennikov D, Güerri-Fernandez R, Ludewig B and Andreas Meyerhans A. Numbers game and immune geography as determinants of coronavirus pathogenicity. Frontiers in Cellular and Infection Microbiology-Virus and Host. Oct 23; 10:559209; doi: 10.3389/fcimb.2020.559209. (2020)

García de Abajo FJ, Hernández RJ, Kaminer I, Meyerhans A, Rosell-Llompart J, Sanchez-Elsner T. Back to Normal: An Old Physics Route to Reduce SARS-CoV-2 Transmission in Indoor Spaces. ACS Nano. Jun 18. doi: 10.1021/acsnano.0c04596. (2020)

Doñate-Macian P , Duarte Y, Rubio-Moscardo F, Pérez-Vilaró G, Canan J, Díez J, González-Nilo F, Valverde MA. Structural determinants of TRPV4 inhibition and identification of new antagonists with antiviral activity. Br J Pharmacol. Sep 2.1 doi: 10.1111/bph.15267 (2020).

Chen TC, Tallo-Parra M, Cao QM, Kadener S, Böttcher R, Pérez-Vilaró G, Boonchuen P, Somboonwiwat K, Díez J, Sarnow P. Host-derived circular RNAs display proviral activities in Hepatitis C virus-infected cells. PLoS Pathog. Aug 7;16(8):e1008346 (2020).

Gonzalez-Cao M, Morán T, Dalmau J, Garcia-Corbacho J, Bracht JWP, Bernabe R, Juan O, de Castro J, Blanco R, Drozdowskyj A, Argilaguet J, Meyerhans A, Blanco J, Prado JG, Carrillo J, Clotet B, Massuti B, Provencio M, Molina-Vila MA, Mayo de Las Casa C, Garzon M, Cao P, Huang CY, Martinez-Picado J, Rosell R. Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study. JAMA Oncol. Apr 9;e200465 (2020).

Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal-Villán E, Jaiswal R, Escalante CR, Gekas C, Meyerhans A, Aramburu J, López-Rodríguez C. The transcription factor NFAT5 limits infection-induced type I interferon responses. J Exp Med. Mar 2;217(3): jem.20190449 (2020).

Shcherbatova O, Grebennikov D, Sazonov I, Meyerhans A, Bocharov G. Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets. Pathogens. Mar 31;9(4):255 (2020).

Bocharov G, Volpert V, Ludewig B, Meyerhans A. Editorial: Mathematical Modeling of the Immune System in Homeostasis, Infection and Disease. Front Immunol. Jan 8;10:2944 (2020).

Prochnow H, Rox K, Birudukota NVS, Weichert L, Hotop SK, Klahn P, Mohr K, Franz S, Banda DH, Blockus S, Schreiber J, Haid S, Oeyen M, Martinez JP, Süssmuth RD, Wink J, Meyerhans A, Goffinet C, Messerle M, Schulz TF, Kröger A, Schols D, Pietschmann T, Brönstrup M. Labyrinthopeptins exert broad-spectrum antiviral activity through lipid-binding-mediated virolysis. J Virol. Jan 6;94(2):e01471-19 (2020). 

Zheltkova V, Argilaguet J, Peligero C, Bocharov G, Meyerhans A. Prediction of PD-L1 inhibition effects for HIV-infected individuals. PLOS Computational Biology. Nov 6;15(11):e1007401 (2019).

Blevins WR, Tavella T, Moro SG, Blasco-Moreno B, Closa-Mosquera A, Díez J, Carey LB, Albà MM. Extensive post-transcriptional buffering of gene expression in the response to severe oxidative stress in baker's yeast. Sci Rep. Jul 29;9(1):11005 (2019).

Grebennikov D, Bouchnita A, Volpert V, Bessonov N, Meyerhans A, Bocharov G. Spatial Lymphocite Dynamics in Lymph Nodes Predicts the Cytotoxic T Cell Frequency Needed for HIV Infection Control. Front Immunol. Jun 11;10:1213 (2019).

Gonzalez-Cao M, Martinez-Picado J, Karachaliou N, Rosell R, Meyerhans A. Cancer immunotherapy of patients with HIV infection. Clin Transl Oncol. Jun;21(6):713-720 (2019).

Argilaguet J, Pedragosa M, Esteve-Codina A, Riera G, Vidal E, Peligero-Cruz C, Casella V, Andreu D, Kaisho T, Bocharov G, Ludewig B, Heath S, Meyerhans A. Systems analysis reveals complex biological processes during virus infection fate decisions. Genome Res. May 28 (2019).

Pedragosa M, Riera G, Casella V, Esteve-Codina A, Steuerman Y, Seth C, Bocharov G, Heath S, Gat-Viks I, Argilaguet J, Meyerhans A. Linking Cell Dynamics With Gene Coexpression Networks to Characterize Key Events in Chronic Virus Infections. Front Immunol. May 3;10:1002 (2019).

Blasco-Moreno B, de Campos-Mata L, Böttcher R, García-Martínez J, Jungfleisch J, Nedialkova DD, Chattopadhyay S, Gas ME, Oliva B, Pérez-Ortín JE, Leidel SA, Choder M, Díez J. The exonuclease Xrn1 activates transcription and translation of mRNAs encoding membrane proteins. Nat Commun. Mar 21;10(1):1298 (2019). 

Gomara MJ, Perez Y, Martinez JP, Barnadas-Rodriguez R, Schultz A, von Briesen H, Peralvarez-Marin A, Meyerhans A, Haro I. Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides. Sci Rep. Mar 1;9(1):3257 (2019).

Bocharov G, Meyerhans A, Bessonov N, Trofimchuk S, Volpert V. Interplay betwwen reaction and diffusion processes in governing the dynamics of virus infections. J Theor Biol. Nov 14;457:221-236 (2018).

Sadiq SK, Mirambeau G, Meyerhans A. Equilibrium Model of Drug-Modulated GagPol-Embedded HIV-1 Reverse Transcriptase Dimerization to Enhance Premature Protease Activation. AIDS Res Hum Retroviruses. Sep;34(9):804-807 (2018).

Gonzalez-Cao M, Karachalou N, Santarpia M, Meyerhans A, Rosell R. Activation of viral defense signaling in cancer. Ther Adv Med Oncol. Aug 29;10: 1758835918793105 (2018). 

Doñate-Macián P, Jungfleisch J, Pérez-Vilaró G, Rubio-Moscardo F, Perálvarez-Marín A, Diez J, Valverde MA. The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity. Nat Commun. Jun 13;9(1):2307 (2018).

Kobayashi-Ishihara M, Terahara K, Martinez JP, Yamagishi M, Iwabuchi R, Brander C, Ato M, Watanabe T, Meyerhans A, Tsunetsugu-Yokota Y. HIV LTR-Driven Antisense RNA by Itself Has Regulatory Function and May Curtail Virus Reactivation From Latency. Front Microbiol. May 25;9:1066 (2018).

Fernández-Carrillo C, Pérez-Vilaró G, Díez J, Pérez-Del-Pulgar S. Hepatitis C virus plays with fire and yet avoids getting burned. A review for clinicians on processing bodies and stress granules. Liver Int. Mar;38(3):388-398 (2018).

Llorens F, Thüne K, Martí E, Kanata E, Dafou D, Díaz-Lucena D, Vivancos A, Shomroni O, Zafar S, Schmitz M, Michel U, Fernández-Borges N, Andréoletti O, Del Río JA, Díez J, Fischer A, Bonn S, Sklaviadis T, Torres JM, Ferrer I, Zerr I. Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis. PLoS Pathog. Jan 22;14(1):e1006802 (2018).

Olvera A, Martinez JP, Casadellà M, Llano A, Rosás M, Mothe B, Ruiz-Riol M, Arsequell G, Valencia G, Noguera-Julian M, Paredes R, Meyerhans A, Brander C. Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro. Front Immunol. Jan 26;8:2010 (2018).

Bouchnita A,  Bocharov G, Meyerhans A, Volpert V. Hybrid approach to model the spatial regulation of T cell responses. BMC Immunology. 18 (Suppl 1):29 (2017)

Fleta-Soriano E, Smutná K, Martinez JP, Lorca Oró C, Sadiq SK, Mirambeau G, Lopez-Iglesias C, Bosch M, Pol A, Brönstrup M, Diez J, Meyerhans A. The myxobacterial metabolite Soraphen A inhibits HIV-1 by reducing virus production and altering virion composition. Antimicrob Agents Chemother.  May 22. pii: AAC.00739-17 (2017)

Díez J, Jungfleisch J. Translation control: Learning from viruses, again. RNA Biol.  May 10:1-3 (2017).

Koutsoudakis G, Paris de León A, Herrera C, Dorner M, Pérez-Vilaró G, Lyonnais S, Grijalvo S, Eritja R, Meyerhans A, Mirambeau G, Díez J. Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo. Antimicrob Agents Chemother.  Apr 24;61(5). pii: e02354-6. (2017).

Chen HC, Martinez JP, Zorita E, Meyerhans A, Filion GJ. Position effects influence HIV latency reversal. Nat Struct Mol Biol. Jan;24(1):47-54 (2017).

Jungfleisch J, Nedialkova DD, Dotu I, Sloan KE, Martinez-Bosch N, Brüning L, Raineri E, Navarro P, Bohnsack MT, Leidel SA, Díez J. A novel translational control mechanism involving RNA structures within coding sequences.  Genome Res. Jan;27(1):95-106 (2017).

Jungfleisch J, Blasco-Moreno B, Díez J. Use of Cellular Decapping Activators by positive-Strand RNA Viruses. Viruses. Dec 21;8(12) (2016).

Bocharov G, Meyerhans A, Bessonov N, Trofimchuk S, Volpert V. Spatiotemporal Dynamics of Virus Infection Spreading in Tissues. PLoS One. Dec 20;11(12):e0168576 (2016).

Neubauer JC, Sébastien I, Germann A, Müller SC, Meyerhans A, von Briesen H, Zimmermann H. Towards Standardized Automated Immunomonitoring: an Automated ELISpot Assay for Safe and Parallelized Functionality Analysis of Immune Cells. Cytotechnology. Nov 28 (2016).

Tsunetsugu-Yokota Y, Kobayahi-Ishihara M, Wada Y, Terahara K, Takeyama H, Kawana-Tachikawa A, Tokunaga K, Yamagishi M, Martinez JP, Meyerhans A. Homeostatically Maintained Resting Naive CD4+ T Cells Resist Latent HIV Reactivation. Front Microbiol. Dec 1;7:1944 (2016).

Carreras-Sureda A, Rubio-Moscardo F, Olvera A, Argilaguet J, Kiefer K, Mothe B, Meyerhans A, Brander C, Vicente R. Lymphocyte Activation Dynamics Is Shaped by Hereditary Components at Chromosome Region 17q12-q21. PLoS One. Nov 11;11(11):e0166414 (2016).

Brai A, Fazi R, Tintori C, Zamperini C, Bugli F, Sanguinetti M, Stigliano E, Esté J, Badia R, Franco S, Martinez MA, Martinez JP, Meyerhans A, Saladini F, Zazzi M, Garbelli A, Maga G, Botta M. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci U S A. May 10;113(19):5388-93 (2016).

Sanchez-Merino V, Fabra-Garcia A, Gonzalez N, Nicolas D, Merino-Mansilla A, Manzardo C, Ambrosioni J, Schultz A, Meyerhans A, Mascola JR, Gatell JM, Alcami J, Miro JM, Yuste E. Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection. J Virol. May 12;90(11):5231-45 (2016).

Latorre I, Esteve-Sole A, Redondo D, Giest S, Argilaguet J, Alvarez S, Peligero C, Forstmann I, Crespo M, Pascual J, Meyerhans A. Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients. Transpl Immunol. Mar;35:1-6 (2016).

RM Tretyakova, A Meyerhans, GA Bocharov. A drug pharmacodynamics and pharmacokinetics based approach towards stabilization of HIV infection dynamics. Russian Journal of Numerical Analysis and Mathematical Modelling 30 (5), 299-310 (2015).

GA Bocharov, IS Telatnikov, VA Chereshnev, J Martinez, A Meyerhans. Mathematical modelling of the within-host HIV quasispecies dynamics in response to antiviral treatment. Russian Journal of Numerical Analysis and Mathematical Modelling 30 (3), 157-170 (2015).

HT Banks, DF Kapraun, KG Link, WC Thompson, C Peligero, J Argilaguet, A. Meyerhans. Analysis of variability in estimates of cell proliferation parameters for cyton-based models using CFSE-based flow cytometry data. Journal of Inverse and Ill-posed Problems 23 (2), 135-171 (2015).

HT Banks, DF Kapraun, C Peligero, J Argilaguet, A Meyerhans. Evaluating the importance of mitotic asymmetry in cyton-based models for CFSE-based flow cytometry data. Int. J. Pure Appl. Math 100, 131-156 (2015). 

Elsebai MF, Koutsoudakis G, Saludes V, Pérez-Vilaró G, Turpeinen A, Mattila S, Pirttilä AM, Fontaine-Vive F, Mehiri M, Meyerhans A, Diez J. Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke. J Virol. Dec;90(4):1918-30 (2015).

Peligero C., Argilaguet JM., Güerri-Fernandez R., Torres B., Ligero C., Colomer P., Plana m., Knobel H., García F. and Meyerhans A. PD-L1 blockade differentially impacts regulatory T cells from HIV-infected individuals depending on plasma viremia. PLoS Pathogens Dec;11(12):e1005270 (2015).

Bocharov G, Argilaguet J, Meyerhans A. Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models. J Immunol Res. 2015:739706 (2015).

Piron M., Plasencia A., Fleta-Soriano E., Martinez A., Martinez JP., Torner N., Sauleda S., Meyerhans A., Escalé J., Trilla A., Pumarola T., Martinez MJ. Low Seroprevalence of West Nile Virus in Blood Donors from Catalonia, Spain. Vector Borne Zoonotic Dis. Dec;15(12):782-4 (2015).

Koutsoudakis G, Romero-brey I, Berger C, Pérez-Vilaró G, Perin PM, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martines JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J. Soraphen A: a broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity. J Hepatol. Oct;63(4):813-21 (2015).

Jungfleisch J, Chowdhury A, Alves-Rodrigues I, Tharun S, Díez J. The Lsm1-7-Pat1 complex promotes viral RNA translation and replication by different mechanisms. RNA. Aug;21(8):1469-79 (2015).

Latorre I, Leidinger P, Backes C, Domínguez J, de Souza-Galvão ML, Maldonado J, Prat C, Ruiz-Manzano J, Sánchez F, Casas I, Keller A, von Briesen H, Knobel H, Meese E, Meyerhans A. A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis. Eur Respir J. Apr;45(4):1173-6 (2015).

Berger CT, Llano A, Carlson JM, Brumme ZL, Brockman MA, Cedeño S, Harrigan PR, Kaufmann DE, Heckerman D, Meyerhans A, Brander C. Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1. J Virol. Apr;89(7):4015-9 (2015).

Pérez-Vilaró G., Fernández-Carrillo C., Mensa L., Miquel R., Sanjuan X., Forns X., Pérez-Del-Pulgar S., Díez J. Hepatitis C virus infection inhibits P-body granule formation in human livers. J Hepatol. Apr;62(4):785-90 (2015).

Martinez J.P., Sasse F., Brönstrup M., Diez J. and Meyerhans A. Antiviral drug discovery: broad-spectrum drugs from nature. Nat. Prod. Rep., 32 (1), 29 - 48 (2015).

Latorre, I., Saludes, V., Díez, J., Meyerhans, A. Techniques of nucleic acid-based diagnosis in the management of bacterial and viral infectious diseases. Pages 201 - 216 in Nucleic Acids as Molecular Diagnostics, Editors, E. Meese & A. Keller, Wiley-VCH Verlag GmbH & Co. (2014).

Saludes, V., Latorre, I., Meyerhans, A., Díez, J. MicroRNAs in human microbial infections and disease outcomes. Pages 217 - 240 in Nucleic Acids as Molecular Diagnostics, Editors, E. Meese & A. Keller, Wiley-VCH Verlag GmbH & Co. (2014).

Fleta-Soriano E, Martínez JP, Hinkelmann B, Gerth K, Washausen P, Diez J, Frank R, Sasse F, Meyerhans A. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway. Microb Cell Fact. 13(1):17 (2014).

Martinez JP, Pérez-Vilaró, G, Muthukumar, Y, Scheller, N, Hirsch, T, Diestel, R, Steinmetz, H, Jansen, R, Frank R, Sasse F, Meyerhans A, Diez J. Screening of small molecules affecting mammalian P-body assembly uncovers links with diverse intracellular processes and organelle physiology. RNA Biol. 10(11):1661-1669 (2013).

Carnero E, Díez J, Fortes P, Gastaminza P, Majano P, Martínez MA, Pérez-Del-Pulgar S, Quer J, López-Labrador FX. eeting Report: 20 years after the First International Symposium on hepatitis C virus and related viruses. Gastroenterol Hepatol. S0210-5705 (2013).

Giménez-Barcons M, Alves-Rodrigues I, Jungfleisch J, Van Wynsberghe PM, Ahlquist P, Díez J. 2013. The cellular decapping activators LSm1, Pat1, and Dhh1 control the ratio of subgenomic to genomic Flock House virus RNAs. J Virol. 87:6192-6200 (2013).

Martinez JP, Hinkelmann B, Fleta-Soriano E, Steinmetz H, Jansen R, Diez J, Frank R, Sasse F, Meyerhans A. Identification of Myxobacteria-derived HIV inhibitors by a high-throughput two-step infectivity assay. Microb Cell Fact. 12(1):85-93 (2013).

Banks HT, Kapraun DF, Thompson WC, Peligero C, Argilaguet J, Meyerhans A. A novel statistical analysis and interpretation of flow cytometry data. J Biol Dyn. 7(1):96-132 (2013).

Huffman, T, Kathryn, L, Nardini; J, Poag, L, Flore, K, Banks, HT, Blasco, B, Jungfleisch, J, Diez J. A mathematical model of RNA3 recruitment in the replication cycle of Brome mosaic virus. Int. J. of Pure and Applied Math. 89(2): 251- 274 (2013).

Chereshnev VA, Bocharov G, Bazhan S, Bachmetyev B, Gainova I, Likhoshvai V, Argilaguet JM, Martinez JP, Rump JA, Mothe B, Brander C, Meyerhans A. Pathogenesis and Treatment of HIV Infection: The Cellular, the Immune System and the Neuroendocrine Systems Perspective. Int Rev Immunol. 32(3):282-306 (2013).

H. T. Banks, W. Clayton Thompson, Cristina Peligero, Sandra Giest, Jordi Argilaguet, and Andreas Meyerhans. A division-dependent compartmental model for computing cell numbers in CFSE-based lymphocyte proliferation assays. Math Biosci Eng 9, 699-736 (2012).

D. Kamdem Toukam, M. Tenbusch, A. Stang, V. Temchura, M. Storcksdieck Genannt Bonsmann, B. Grewe, S. Koch, A. Meyerhans, G. Nchinda, L. Kaptue, and K. Uberla. Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus. PLoS One. 7(5):e38068 (2012).

Plaza, R. Garcia, G. Bifulco, J.P. Martinez, S. Hüttel, F. Sasse, A. Meyerhans, M. Stadler, and R. Müller. Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus "Aetherobacter". Org Lett. 14(11):2854-7 (2012).

R. Suspène and A. Meyerhans. Quantification of unintegrated HIV-1 DNA at the single cell level in vivo. PLoS One. 7(5):e36246 (2012).

Schultz, S. Sopper, U. Sauermann, A. Meyerhans, and R. Suspène. Stable multi-infection of splenocytes during SIV infection--the basis for continuous recombination. Retrovirology. 9:31 (2012).

Schuetz, J. Dirks, U. Sester, A. Haule, N. Elias, C. Geldmacher, E. Sanga, L. Maboko, K. Reither, M. Hoelscher, A. Meyerhans, M. Sester. Pathogen prevalence may determine maintenance of antigen-specific T-cell responses in HIV-infected individuals. AIDS. 26(6):695-700 (2012).

T. Breinig, N. Scheller, B. Glombitza, F. Breinig, and A. Meyerhans. Human yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile. Med Microbiol Immunol. 201(2):127-36 (2012).

Anke Schultz, Stefanie Koch, Martina Fuss, Angela S. Mazzotta, Marcella Sarzotti-Kelsoe, Daniel A. Ozaki, David C. Montefiori, Hagen von Briesen, Heiko Zimmermann, Andreas Meyerhans. An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials. PlosOne 7 (12), e51715 (2012).

G. Bocharov, V. Chereshnev, I. Gainova, S. Bazhan, B. Bachmetyev, J. Argilaguet, J. Martinez, A. Meyerhans. Human Immunodefciency Virus Infection: from Biological Observations to Mechanistic Mathematical Modelling. Math. Model. Nat. Phenom. 7, 78-104 (2012).

H.T. Banks, G. Bocharov, Z. Grossman, and A. Meyerhans. Preface: Distributed Parameter Systems in Immunology. Math. Model. Nat. Phenom. 7, 1-3 (2012).

Pérez-Vilaró, G., Jungfleisch, J., Saludes, V., Scheller, N., Giménez-Barcons, M., and Díez J. Host factors in viral life cycles. Math. Model. Nat. Phenom. 7(5): 123-132 (2012).

Pérez-Vilaró G, Scheller N, Saludes V, Díez J. Hepatitis C virus infection alters P-body composition but is independent of P-body granules. J Virol. 86(16): 8740- 8749 (2012).

Diez J, Martinez JP, Mestres J, Sasse F, Frank R, Meyerhans A. Myxobacteria: natural pharmaceutical factories. Microb Cell Fact. 11: 52- 54 (2012).

Sester M., Giehl C., Kampmann B., Meyerhans A. World-wide challenges and perspectives for handling HIV/Mycobacterium tuberculosis co-infections. The Open Infectious Diseases Journal 5, (Suppl 1-M1) 13 (2011).

Schuetz A., Haule A., Reither K., Ngwenyama N., Rachow A., Meyerhans A., Maboko L., Koup RA., Hoelscher M., Geldmacher C. Monitoring CD27 expression to evaluate Mycobacterium Tuberculosis activity in HIV-1 infected individuals in vivo. PLoS One 6(11):e27284 (2011).

Banks HT., Sutton KL., Thompson WC., Bocharov G., Doumic M., Schenkel T., Argilaguet J., Giest S., Peligero C., Meyerhans A. A new model for the estimation of cell proliferation dynamics using CFSE data. J Immunol Methods 28;373(1-2): 143-60 (2011).

Suspène R., Aynaud MM., Koch S., Pasdeloup D., Labetoulle M., Gaertner B., Vartanian JP., Meyerhans A., Wain-Hobson S. Genetic editing of Herpes Simplex 1 and Epstein Barr herpesvirus genomes by human APOBEC-3 cytidine deaminases in culture and in vivo. J. Virol. 85(15):7594-602 (2011).

Martínez JP., Bocharov G., Ignatovich A., Reiter J., Dittmar MT., Wain-Hobson S., Meyerhans A. Fitness ranking of individual mutants drives patterns of epistatic interactions in HIV-1. PLoS One 31(6):e18375 (2011).

Banks HT, Sutton KL, Clayton Thompson W, Bocharov G, Roose D, Schenkel T, Meyerhans A. Estimation of cell proliferation dynamics using CFSE data. Bull Math Biol 73:116-150 (2011).

Alvarez MA., and the Euco-Net consortium (coordinator: Meyerhans A.). Research priorities for HIV/M. tuberculosis co-infection. The Open Infectious Diseases Journal 5, (Suppl 1-M2) 14-20 (2011).

Giménez-Barcons M, Díez J. Yeast processing bodies and stress granules: self-assembly ribonucleoprotein particles.Microb Cell Fact. 10: 73 (2011).

Ehrhardt, M., Leidinger, P., Keller, K., Baumert, T.F., Díez, J., Meese, E., Meyerhans, A. Profound differences of miRNA expression patterns in hepatocytes and hepatoma cell lines commonly used in HCV studies. Hepatology. 54 (3):11111-11112. (2011).

Reiter, J., Pérez-Vilaró, G., Scheller, N., Mina, LB., Díez, J., Meyerhans, A. Hepatitis C recombination in cell culture. J Hepatol. 55 (4): 777-783 (2011).

Hoppstädter J, Diesel B, Zarbock R, Breinig T, Monz D, Koch M, Meyerhans A, Gortner L, Lehr CM, Huwer H, Kiemer AK. Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages. Respir Res. 11, 124 (2010).

Herrmann M, Ruprecht K, Sauter M, Martinez J, van Heteren P, Glas M, Best B, Meyerhans A, Roemer K, Mueller-Lantzsch N. Interaction of human immunodeficiency virus gp120 with the voltage-gated potassium channel BEC1. FEBS Lett. 584, 3513-8 (2010).

Sester, M., Giehl, C., Sester, U., and Meyerhans, A. Management of TB in HIV infection: where T cells matter. Eur Respir J 35(3):475-6 (2010).

Galao, RP., Chari, A., Alves-Rodriguez I., Mas A., Kambach C., Fischer, U. and Diez, J. LSm1-7 complex binds to specific sites in viral RNA genomes and regulate their translation and replication. RNA. 16(4): 817-827 (2010).

Sester M, Giehl C, McNerney R, Kampmann B, Walzl G, Cuchí P, Wingfield C, Lange C, Migliori GB, Kritski AL, and Meyerhans A; European Network for global cooperation in the field of AIDS and TB (EUCO-Net). Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur Respir J. 36(6):1242-7 (2010).

Ferraz, R.M., Rodriguez-Carmona, E., Ferrer-Miralles, N., Meyerhans, A., and Villaverde, A. Screening HIV-1 antigenic peptides as receptors for antibodies and CD4 in allosteric nanosensors. J Mol Recognit 22, 255-260 (2009).

Gorjup, E., Danner, S., Rotter, N., Habermann, J., Brassat, U., Brummendorf, T.H., Wien, S., Meyerhans, A., Wollenberg, B., Kruse, C. , et al. Glandular tissue from human pancreas and salivary gland yields similar stem cell populations. Eur J Cell Biol 88, 409-421 (2009).

Scheller N and Díez J. RNA viruses hijack the mRNA decay machinery to multiply. Cell Cycle. 8(24): 4013- 4014 (2009).

Scheller N, Mina LB, Galão RP, Giménez M, Chari A, Noueiry A, Fischer U, Meyerhans A, Díez J. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc. Natl. Acad Sci. USA. 106(32): 13517-22 (2009).

Schneider, K., Kromer, JO., Wittmann, C., Alves-Rodriguez, I., Meyerhans, A., Díez, J., Heinzle, E. Metabolite profiling studies in Saccharomyces cerevisiae: an assisting tool to prioritize host targets for antiviral drug screening. Microb. Cell Fact. 8: 12 ( 2009).